CN105410346A - Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof - Google Patents
Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof Download PDFInfo
- Publication number
- CN105410346A CN105410346A CN201510720449.XA CN201510720449A CN105410346A CN 105410346 A CN105410346 A CN 105410346A CN 201510720449 A CN201510720449 A CN 201510720449A CN 105410346 A CN105410346 A CN 105410346A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- survival rate
- preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 100
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 230000004083 survival effect Effects 0.000 title claims abstract description 47
- 241000238553 Litopenaeus vannamei Species 0.000 title abstract description 34
- 241000238557 Decapoda Species 0.000 claims abstract description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 17
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 230000002829 reductive effect Effects 0.000 claims description 14
- 239000004744 fabric Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 6
- 230000004087 circulation Effects 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 3
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 238000002203 pretreatment Methods 0.000 claims description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims 2
- 235000003097 Artemisia absinthium Nutrition 0.000 claims 2
- 240000001851 Artemisia dracunculus Species 0.000 claims 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims 2
- 240000003109 Persicaria chinensis Species 0.000 claims 2
- 239000001138 artemisia absinthium Substances 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 229920001617 Vinyon Polymers 0.000 claims 1
- 239000011149 active material Substances 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 26
- 210000004185 liver Anatomy 0.000 abstract description 20
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 abstract description 19
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract description 18
- 210000002784 stomach Anatomy 0.000 abstract description 16
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 abstract description 13
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 abstract description 13
- 241000411851 herbal medicine Species 0.000 abstract description 11
- 240000001972 Gardenia jasminoides Species 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 239000000654 additive Substances 0.000 abstract description 8
- 238000009395 breeding Methods 0.000 abstract description 8
- 230000001488 breeding effect Effects 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 5
- 235000018958 Gardenia augusta Nutrition 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 46
- 229940079593 drug Drugs 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 239000000546 pharmaceutical excipient Substances 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 13
- 239000004568 cement Substances 0.000 description 13
- 241000391134 Pasiphaeidae Species 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 10
- 206010023126 Jaundice Diseases 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 244000025254 Cannabis sativa Species 0.000 description 9
- 241000607768 Shigella Species 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 244000111489 Gardenia augusta Species 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000001780 epistaxis Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 240000005979 Hordeum vulgare Species 0.000 description 7
- 241000736199 Paeonia Species 0.000 description 7
- 239000003674 animal food additive Substances 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 241000628997 Flos Species 0.000 description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- -1 arylmethyl acetophenone Chemical compound 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001784 detoxification Methods 0.000 description 6
- 238000009313 farming Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 5
- 240000001592 Amaranthus caudatus Species 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 5
- 241000927735 Penaeus Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 208000037386 Typhoid Diseases 0.000 description 5
- 239000004178 amaranth Substances 0.000 description 5
- 235000012735 amaranth Nutrition 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 201000008297 typhoid fever Diseases 0.000 description 5
- 201000000297 Erysipelas Diseases 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 208000004078 Snake Bites Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 206010013023 diphtheria Diseases 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 208000028774 intestinal disease Diseases 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 208000018556 stomach disease Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 235000001405 Artemisia annua Nutrition 0.000 description 3
- 240000000011 Artemisia annua Species 0.000 description 3
- 208000004429 Bacillary Dysentery Diseases 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 3
- 240000005385 Jasminum sambac Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010057249 Phagocytosis Diseases 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 3
- 229960004191 artemisinin Drugs 0.000 description 3
- 229930101531 artemisinin Natural products 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 210000001630 jejunum Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 239000008820 moutan cortex Substances 0.000 description 3
- 230000008782 phagocytosis Effects 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000005113 shigellosis Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000008658 Artemisia capillaris Nutrition 0.000 description 2
- 241000092668 Artemisia capillaris Species 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000995704 Fenneropenaeus chinensis Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000606768 Haemophilus influenzae Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 238000012404 In vitro experiment Methods 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 241000223229 Trichophyton rubrum Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 238000009364 mariculture Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- XNGKCOFXDHYSGR-UHFFFAOYSA-N perillene Chemical compound CC(C)=CCCC=1C=COC=1 XNGKCOFXDHYSGR-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- GUAFOGOEJLSQBT-UHFFFAOYSA-N scoparone Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- GXFZCDMWGMFGFL-KKXMJGKMSA-N (+)-Tubocurarine chloride hydrochloride Chemical compound [Cl-].[Cl-].C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CC[NH+]3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 GXFZCDMWGMFGFL-KKXMJGKMSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DCSCXTJOXBUFGB-JGVFFNPUSA-N (R)-(+)-Verbenone Natural products CC1=CC(=O)[C@@H]2C(C)(C)[C@H]1C2 DCSCXTJOXBUFGB-JGVFFNPUSA-N 0.000 description 1
- DCSCXTJOXBUFGB-SFYZADRCSA-N (R)-(+)-verbenone Chemical compound CC1=CC(=O)[C@H]2C(C)(C)[C@@H]1C2 DCSCXTJOXBUFGB-SFYZADRCSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241001633583 Adenophora Species 0.000 description 1
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 241001184073 Basilicum Species 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 240000008555 Canna flaccida Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241001111317 Chondrodendron tomentosum Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 239000008709 Curare Substances 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000234653 Cyperus Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000735527 Eupatorium Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000258240 Mantis religiosa Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 201000000090 Microsporidiosis Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000124079 Mylabris Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000124464 Paeonia veitchii Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000238552 Penaeus monodon Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001495452 Podophyllum Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000353135 Psenopsis anomala Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 235000006966 Uapaca guineensis Nutrition 0.000 description 1
- 240000007668 Uapaca guineensis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000004934 Vitex trifolia Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229960005004 cholera vaccine Drugs 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000010015 huanglian Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- YUPOCHDBBHTUBJ-UHFFFAOYSA-N nonadecan-10-one Chemical compound CCCCCCCCCC(=O)CCCCCCCCC YUPOCHDBBHTUBJ-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 239000008678 sanqi Substances 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 1
- 229960001544 sulfathiazole Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 229960001266 typhoid vaccines Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- DCSCXTJOXBUFGB-UHFFFAOYSA-N verbenone Natural products CC1=CC(=O)C2C(C)(C)C1C2 DCSCXTJOXBUFGB-UHFFFAOYSA-N 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000008434 yi-zhi Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了提高养殖对虾存活率的中药制剂,包括以下重量份数的中药组分:火炭母:30-40份;山栀子:20-30份;茵陈:20-30份;大青叶:15-25份;山银花:15-25份;马齿苋:15-25份;赤芍:20-30份;丹皮:20-30份;麦芽:20-30份;可溶性辅料:35-45份。通过在饲料中加入以火炭母、山栀子、茵陈、大青叶、山银花、马齿苋、赤芍、丹皮和麦芽为原料经现代制药技术加工而成的中草药添加剂,具有清热利湿,解毒护肝,健胃消食的功效,经过科学养殖实验表明,能够显著提高南美白对虾的存活率,使用后最高的南美白对虾养殖成活率可以达到98%,显著促进南美白对虾生长,同时还能显著降低水体的氨氮值。更重要的是,中草药不会给对虾及饲养环境带来副作用,且本发明的中草药原料价格便宜,简单易得。The invention discloses a traditional Chinese medicine preparation for improving the survival rate of cultured prawns, which comprises the following traditional Chinese medicine components in parts by weight: mother of fire: 30-40 parts; gardenia jasminoides: 20-30 parts; Leaf: 15-25 parts; Mountain Yinhua: 15-25 parts; Purslane: 15-25 parts; Paeoniae Rubra: 20-30 parts; Paeonol: 20-30 parts; Malt: 20-30 parts; soluble auxiliary materials : 35-45 servings. By adding Chinese herbal medicine additives processed by modern pharmaceutical technology, which are processed by modern pharmaceutical technology, with Huotanmu, Shanzhizi, Yinchen, Daqingye, Liqun, purslane, red peony, paeonol and malt, it has the effect of clearing away heat. The effects of promoting dampness, detoxifying and protecting the liver, invigorating the stomach and eliminating food, scientific breeding experiments have shown that it can significantly increase the survival rate of Penaeus vannamei. After use, the highest survival rate of Penaeus vannamei can reach 98%, which can significantly promote the growth of Penaeus vannamei , At the same time, it can significantly reduce the ammonia nitrogen value of the water body. More importantly, the Chinese herbal medicine will not bring side effects to the prawns and the feeding environment, and the raw materials of the Chinese herbal medicine of the present invention are cheap and easy to obtain.
Description
技术领域 technical field
本发明涉及海产品养殖技术领域,具体是一种显著促进对虾生长、提高养殖对虾存活率的中药制剂及其制备方法。 The invention relates to the technical field of marine product cultivation, in particular to a traditional Chinese medicine preparation which significantly promotes the growth of prawns and improves the survival rate of cultured prawns and a preparation method thereof.
背景技术 Background technique
对虾是一种名贵的海产虾类。世界各地海洋中所产品种甚多,有斑节对虾、墨吉对虾、南美白对虾、短沟对虾等。对虾因其营养丰富,且其肉质松软,易消化而深受人们喜爱。由于海洋渔业资源衰竭,人们对对虾的需求越来越依赖人工养殖,因此,世界范围内的对虾养殖业发展迅速。在海水养殖中,养殖对虾的附加值是比较大的,但养殖的风险也比较大,这是因为对虾在养殖过程中,极容易因为气候环境、水体水质、喂养饲料、喂养方式及常见疾病的因素,影响对虾的生长,造成对虾存活率低。传统的给药方法不良作用较大,如抗生素治疗南美白对虾常见病有一定的疗效,但是副作用较大,如易产生抗药性、体内蓄积、破坏水体生态平衡等,有些还因药物残留导致对虾品质下降。检索到以下关于对虾养殖采用中药成分作为饲料添加剂的中国专利: Prawn is a kind of rare seafood shrimp. There are many species produced in the oceans all over the world, including Penaeus monodon, Penaeus moji, Penaeus vannamei, and Penaeus shortgroove. Prawns are very popular because of their rich nutrition, soft meat and easy digestion. Due to the depletion of marine fishery resources, people's demand for prawns is increasingly dependent on artificial farming. Therefore, the worldwide prawn farming industry is developing rapidly. In mariculture, the added value of shrimp farming is relatively large, but the risk of farming is also relatively high. This is because during the breeding process of shrimp, it is very easy to suffer from changes in climate, water quality, feeding feed, feeding methods and common diseases. Factors affect the growth of prawns, resulting in low survival rate of prawns. Traditional drug administration methods have relatively large adverse effects. For example, antibiotics have certain curative effects in the treatment of common diseases of Penaeus vannamei, but they have relatively large side effects, such as drug resistance, accumulation in the body, and damage to the ecological balance of water bodies. Quality drops. The following Chinese patents on the use of traditional Chinese medicine ingredients as feed additives in shrimp farming were retrieved:
申请号:200710059732.8;申请人:天津农学院;发明人:邢克智,陈成勋,白东清,郭永军;发明名称:南美白对虾饲养用中药组合物;摘要:本发明属于饲料添加药物领域,特别是南美白对虾饲养用中草药领域。南美白对虾饲养用中药组合物,主要包括以下组分,并以以下重量比组合:川断10~15,白术15-25,白芍10-18,女贞子10-15,大黄10~15,金银花8~15,黄芪8~15,柴胡3~10,本发明可提高溶菌酶含量,血淋巴吞噬能力,提高超氧化物歧化酶(sod)、过氧化氢脱氢酶(cat)水平,避免了抗生素类药物作用不够全面、大量使用有一定的副作用的缺陷,预防使用的有效率可以达到100%,使用后最高的南美白对虾养殖成活率可以达到73%。 Application number: 200710059732.8; Applicant: Tianjin Agricultural College; Inventors: Xing Kezhi, Chen Chengxun, Bai Dongqing, Guo Yongjun; Invention name: Traditional Chinese medicine composition for feeding Penaeus vannamei; Abstract: The present invention belongs to the field of feed additive drugs, especially Penaeus vannamei The field of Chinese herbal medicine for feeding. The traditional Chinese medicine composition for raising Penaeus vannamei mainly includes the following components, which are combined in the following weight ratios: Chuanduan 10-15, Atractylodes macrocephala 15-25, Baishao 10-18, Ligustrum lucidum 10-15, rhubarb 10-15 , honeysuckle 8-15, Astragalus 8-15, Bupleurum 3-10, the present invention can increase the content of lysozyme, hemolymph phagocytosis, and improve the levels of superoxide dismutase (sod) and hydrogen peroxide dehydrogenase (cat) , to avoid the shortcomings of antibiotics that are not comprehensive enough and have certain side effects when used in large quantities, the effective rate of preventive use can reach 100%, and the highest survival rate of Penaeus vannamei after use can reach 73%.
申请号:201510400768.2;申请人:卞佳林;发明名称:含有中药成分的墨吉对虾的饲料添加剂及饲料制备方法;摘要:本发明公开了一种中药添加剂,按重量份数计,包括以下组分:青蒿6~18份、莎草香附子5~13份、泽兰10~20份、莨菪5~15份、打碗花4~12份、婆婆纳3~9份、肾蕨10~20份、海金沙10~20份、穿山甲6~18份、蝼蛄5~13份、乡球藤4~12份、牛扁6~18份、山荷叶5~15份、瓦草5~10份。本发明还公开了含有上述中药添加剂的墨吉对虾饲料及其制备方法。本发明的饲料中的中药添加剂可以用来提高墨吉对虾的免疫力,预防墨吉对虾得微孢子虫病,而使得产量降低,另外本发明饲料中的红薯藤和松针粉也可以额外补充墨吉对虾所需要的微量元素和营养物质。 Application number: 201510400768.2; Applicant: Bian Jialin; Invention name: Feed additive and feed preparation method of Penaeus prawns containing traditional Chinese medicine ingredients; Abstract: The invention discloses a traditional Chinese medicine additive, which includes the following components in parts by weight: 6-18 parts of Artemisia annua, 5-13 parts of Cyperus cyperus, 10-20 parts of Eupatorium, 5-15 parts of Scopolamine, 4-12 parts of Dawanhua, 3-9 parts of Popona, 10-20 parts of Kidney Fern, 10-20 parts of Haijinsha, 6-18 parts of pangolin, 5-13 parts of mole cricket, 4-12 parts of Xiangqiu vine, 6-18 parts of Niubian, 5-15 parts of mountain lotus leaf, and 5-10 parts of tile grass. The invention also discloses the prawn feed containing the above-mentioned traditional Chinese medicine and a preparation method thereof. The traditional Chinese medicine additive in the feed of the present invention can be used to improve the immunity of Penaeus Moji, and prevent Microsporidiosis of Penaeus Moji, so that the yield is reduced. In addition, the sweet potato vine and pine needle powder in the feed of the present invention can also supplement Moji Trace elements and nutrients needed by prawns.
申请号:201410326350.7;申请人:南宁荣港生物科技有限公司;发明名称:一种对虾用中药饲料添加剂的制备方法;摘要:本发明公开了一种对虾用中药饲料添加剂的制备方法,本发明的中药饲料添加剂常用中药的重量配比为:黄精17-24份、筋骨草15-19份、党参15-19份、黄芪13-18份、苍术8-14份、板蓝根8-13份、穿心莲8-13份。将各药材按比例混合,加工成50-70目的药粉,将药粉加30%的纯净水与适量红糖自然发酵成酵素,提取酵素液后余下的药渣经过高速磨浆机磨成膏状物;将膏状物与提纯过的优质芽孢杆菌、优质酵母菌充分混合再一次发酵36小时,制成本发明对虾用的中药饲料添加剂。本发明具有药性平和、更容易消化和吸收、预防对虾类疾病效果好、对养殖水体无污染的优点。 Application number: 201410326350.7; Applicant: Nanning Ronggang Biotechnology Co., Ltd.; Invention name: A preparation method of a traditional Chinese medicine feed additive for prawns; Abstract: This invention discloses a preparation method of a Chinese medicine feed additive for prawns. The weight ratio of traditional Chinese medicine commonly used in Chinese medicine feed additives is: Rhizoma Polygonatum 17-24 parts, Grass sinensis 15-19 parts, Codonopsis 15-19 parts, Astragalus 13-18 parts, Atractylodes 8-14 parts, Radix Radix 8-13 parts, Andrographis paniculata 8 -13 copies. Mix the medicinal materials in proportion and process them into medicinal powders of 50-70 meshes. Add 30% pure water and appropriate amount of brown sugar to the medicinal powders to ferment naturally into enzymes. After extracting the enzyme liquid, the remaining medicinal residues are ground into a paste by a high-speed refiner; The paste is fully mixed with the purified high-quality bacillus and high-quality yeast and fermented again for 36 hours to make the traditional Chinese medicine feed additive for prawns of the present invention. The invention has the advantages of mild medicinal properties, easier digestion and absorption, good effect of preventing shrimp diseases and no pollution to aquaculture water.
申请号:201510401431.3;申请人:卞佳林;发明名称:一种中国对虾的饲料用中药添加剂;摘要:本发明公开了一种中药添加剂,按重量份数计,包括以下组分:沙参12~20份、徐长卿10~20份、角蒿10~20份、曼荆5~15份、长松罗4~12份、狗脊蕨3~9份、玳瑁10~20份、螳螂10~20份、小毛莨6~18份、鬼臼5~13份、草麻黄4~12份、益智6~18份、姜三七5~15份、美人蕉5~10份。本发明还公开了含有上述中药添加剂的中国对虾饲料及其制备方法。本发明的饲料中的中药添加剂可以用来提高中国对虾的免疫力,预防中国对虾得病毒性疾病,而使得产量降低,另外本发明饲料中的红薯藤、蚌壳粉和松针粉也可以额外补充中国对虾所需要的微量元素和营养物质。 Application number: 201510401431.3; Applicant: Bian Jialin; Invention name: A Chinese medicine additive for Chinese prawn feed; Abstract: The invention discloses a Chinese medicine additive, which includes the following components in parts by weight: Adenophora 12-20 10 to 20 parts of Xu Changqing, 10 to 20 parts of Artemisia annua, 5 to 15 parts of Manjing, 4 to 12 parts of Long Song Luo, 3 to 9 parts of dog ridge fern, 10 to 20 parts of tortoiseshell, 10 to 20 parts of praying mantis, 6-18 parts of buttercup, 5-13 parts of podophyllum, 4-12 parts of ephedra, 6-18 parts of Yizhi, 5-15 parts of ginger Sanqi, and 5-10 parts of canna. The invention also discloses a Chinese prawn feed containing the above-mentioned traditional Chinese medicine additive and a preparation method thereof. The Chinese medicine additive in the feed of the present invention can be used to improve the immunity of Penaeus chinensis, prevent the viral diseases of Penaeus chinensis, and reduce the yield. In addition, the sweet potato vine, clam shell powder and pine needle powder in the feed of the present invention can also be additionally supplemented Trace elements and nutrients needed by Chinese prawns.
但是目前还没有文献公开过以火炭母、山栀子、茵陈、大青叶、赤芍、丹皮及麦芽等中药原料制成的中药制剂,并用于促进对虾生长、提高对虾养殖成活率、降低水体氨氮方面的专利。本发明研制的中药制剂,具有清热利湿,解毒护肝,健胃消食的功效,经过科学养殖实验表明,能够显著提高南美白对虾的存活率,使用后最高的南美白对虾养殖成活率可以达到98%,显著促进南美白对虾生长,同时还能显著降低水体的氨氮值。 But at present there is no document disclosing traditional Chinese medicine preparations made from traditional Chinese medicine raw materials such as Fotanmu, Gardenia jasminoides, capillary, Daqingye, red peony root, paeonol and malt, and are used to promote the growth of prawns, improve the survival rate of prawns, Patents on reducing ammonia nitrogen in water. The traditional Chinese medicine preparation developed by the present invention has the functions of clearing away heat and promoting dampness, detoxifying and protecting the liver, and invigorating the stomach and eliminating food. Scientific breeding experiments have shown that it can significantly improve the survival rate of Penaeus vannamei, and the highest survival rate of Penaeus vannamei after use can reach 98%, significantly promoting the growth of Penaeus vannamei, and at the same time significantly reducing the ammonia nitrogen value of the water body.
发明内容 Contents of the invention
本发明要解决的技术问题是提供一种能显著促进对虾生长、提高养殖对虾养殖成活率、降低水体氨氮的中药制剂及其制备方法。 The technical problem to be solved by the present invention is to provide a traditional Chinese medicine preparation that can significantly promote the growth of prawns, improve the survival rate of cultured prawns, and reduce ammonia nitrogen in water bodies and a preparation method thereof.
本发明采取如下技术方案: The present invention takes following technical scheme:
提高养殖对虾存活率的中药制剂,包括以下重量份数的中药组分: The traditional Chinese medicine preparation for improving the survival rate of cultured prawns comprises the following traditional Chinese medicine components in parts by weight:
火炭母:30-40份;山栀子:20-30份;茵陈:20-30份;大青叶:15-25份;山银花:15-25份;马齿苋:15-25份;赤芍:20-30份;丹皮:20-30份;麦芽:20-30份;可溶性辅料:35-45份。 Fotan mother: 30-40 parts; Gardenia: 20-30 parts; Capillary: 20-30 parts; Daqingye: 15-25 parts; Mountain Yinhua: 15-25 parts; parts; red peony: 20-30 parts; paeonol: 20-30 parts; malt: 20-30 parts; soluble excipients: 35-45 parts.
以上所述的提高养殖对虾存活率的中药制剂药材配方的各有效组份分析: The analysis of each effective component of the traditional Chinese medicine preparation medical material formula of improving the survival rate of cultured prawns mentioned above:
火炭母,【拉丁学名】PolygonumChinenseL.;【别名】火炭星、盲更蔗、天师印、假糖梅、斑鸠饭、毛甘蔗。【功效】清热解毒,利湿消滞,凉血止痒,明止退翳。【主治】用于痢疾,消化不良,肝炎,感冒,扁桃体炎,咽喉炎,白喉,百日咳,角膜云翳,乳腺炎,霉菌性阴道炎,白带,疖肿,小儿脓疱,湿疹,毒蛇咬伤。【药用价值】1.抗菌作用:本品煎剂对志贺、斯密茨、福氏和宋内痢疾杆菌的抗菌效价分别为1:512,1:128,1:64,1:15。此外,本品煎剂对金黄色葡萄球菌、乙型链球菌、炭疽杆菌、白喉杆菌、枯草杆菌、伤寒杆菌、绿脓杆菌及流感嗜血杆菌等也有较强抗菌作用。2.抗病毒作用:本品煎剂鸡胚外抗病毒试验,对亚洲甲型流感病毒和副流感Ⅰ型病毒的抗病毒效价分别为1:160和1:64,鸡胚内试验则效果不明显。3.其他作用:本品的95%乙醇提取物对肾性高血压大鼠有抗高血压作用。有效成分3,3′-二甲基并没食子酸给予清醒的肾性高血压大鼠,对心收缩力和血压有显著影响[3].Ames试验,本品水提取物有一定抗诱变作用,诱变抑制率在10%以上。此外,本品对实验动物肿瘤有抑制作用,扛板归明胶纤维素有止血作用。 Fotan Mother, [Latin scientific name] PolygonumChinenseL .; [alias] Fotan Star, Blind Gengcane, Tianshi Yin, Fake Sugar Plum, Turtle Dove Rice, Hairy Sugarcane. 【Efficacy】clearing away heat and detoxification, promoting dampness and eliminating stagnation, cooling blood and relieving itching, brightening and relieving nebula. [Indications] For dysentery, dyspepsia, hepatitis, cold, tonsillitis, pharyngitis, diphtheria, whooping cough, corneal clouding, mastitis, fungal vaginitis, leucorrhea, furuncle, pustule in children, eczema, snake bites. [Medicinal value] 1. Antibacterial effect: The antibacterial efficacy of this decoction against Shiga, Schmitz, Flexneri and Shigella sonnei are 1:512, 1:128, 1:64, 1:15 respectively . In addition, the decoction of this product also has a strong antibacterial effect on Staphylococcus aureus, Streptococcus B, Bacillus anthracis, Bacillus diphtheria, Bacillus subtilis, Bacillus typhi, Pseudomonas aeruginosa and Haemophilus influenzae. 2. Antiviral effect: The decoction of this product has been tested for antiviral activity outside the chicken embryo. The antiviral titers against Asian influenza A virus and parainfluenza I virus are 1:160 and 1:64 respectively. Not obvious. 3. Other effects: 95% ethanol extract of this product has antihypertensive effect on rats with renal hypertension. The active ingredient 3,3′-dimethyl gallic acid has a significant effect on cardiac contractility and blood pressure when administered to conscious renal hypertensive rats [3]. Ames test shows that the water extract of this product has a certain anti-mutagenic effect , The mutagenesis inhibition rate is above 10%. In addition, this product has an inhibitory effect on experimental animal tumors, and the gelatin cellulose has a hemostatic effect.
山栀子,【拉丁学名】GardeniajasminoidesEllis;【别名】黄栀子、黄果树、红枝子;为茜草科植物栀子GardeniajasminoidesEllis的干燥成熟果实,属卫生部颁布的第1批药食两用资源,具有护肝、利胆、降压、镇静、止血、消肿等作用。在中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症。【功能主治】清热,泻火,凉血。治热病虚烦不眠,黄疸,淋病,消渴,目赤,咽痛,吐血,衄血,血痢,尿血,热毒疮疡,扭伤肿痛。①《本经》:“主五内邪气,胃中热气,面赤,酒疱皶鼻,白癞,赤癞,疮疡。”②《本草经集注》:“解踯躅毒。”③《别录》:“疗目热亦痛,胸心、大小肠大热,心中烦闷,胃中热气。”④《药性论》:“杀蟅虫毒,去热毒风,利五淋,主中恶,通小便,解五种黄病,明目,治时疾除热及消渴口干,目赤肿痛。”⑤《食疗本草》:“主瘖哑,紫癜风,黄疸积热心躁。”⑥《医学启源》:“疗心经客热,除烦躁,去上焦虚热,治风。”⑦《药类法象》:“治心烦懊憹而不得眠,心神颠倒欲绝,血滞而小便不利。”⑧朱震亨:“泻三焦火,清胃脘血,治热厥心痛,解热郁,行结气。”⑧《纲目》:“治吐血、衄血、血痢、下血、血淋,损伤瘀血,及伤寒劳复,热厥头痛,疝气,汤火伤。”⑩《本草备要》:“生用泻火,炒黑止血,姜汁炒治烦呕,内热用仁,表热用皮。”⑾广州部队《常用中草药手册》:“清热解毒,凉血泻火。治黄疸型肝炎,蚕豆黄,感冒高热,菌痢,肾炎水肿,鼻衄,口舌生疮,乳腺炎,疮疡肿毒。”山栀子还具有抗微生物作用,即栀子水漫液在试臂内对许兰氏黄癣菌,腹股沟表皮癣菌、红色表皮癣菌等多种真菌有抑制作用,其水煎剂15毫克/毫升能杀死钩端螺旋体,在体外,栀子煎剂能使血吸虫停止活动,煎剂对细菌生长无抑制作用。栀子醇提取液对家兔及大白鼠离体肠管平滑肌,低浓度兴奋,高浓度抑制。去羟栀子甙对小鼠有泻下作用,其提取物制成油膏,可加速软组织的愈合。 Gardenia jasminoides, [Latin scientific name] Gardenia jasminoides Ellis; [alias] yellow gardenia, yellow fruit tree, red branch; it is the dry and mature fruit of Rubiaceae Gardenia jasminoides Ellis, which belongs to the first batch of medicinal and edible resources promulgated by the Ministry of Health. Liver protection, choleretic, blood pressure lowering, sedation, hemostasis, swelling and other effects. In traditional Chinese medicine, it is often used to treat jaundice hepatitis, sprains, high blood pressure, diabetes and other diseases. [function cures mainly] heat-clearing, purging fire, cooling blood. Treatment of febrile disease, restlessness, jaundice, gonorrhea, thirst, red eyes, sore throat, hematemesis, epistaxis, dysentery, hematuria, toxic heat sores, sprains and swelling. ① "The Classic": "maintain five internal evils, heat in the stomach, flushed face, wine blisters and nose, white leprosy, red leprosy, sores.""Bielu":"Treating eye heat and pain, chest, heart, large and small intestine heat, heart distress, and heat in the stomach." ④ "Medicine Properties": "Killing weed poison, removing heat and wind, benefiting five stranguria, and controlling the middle Evil, relieves urination, relieves five kinds of jaundice, improves eyesight, treats seasonal diseases and eliminates heat and thirst, dry mouth, red eyes, swelling and pain." ⑤ "Diet Therapy Materia Medica": "Mainly dullness, purpura, jaundice with accumulated heat and restlessness. ⑥ "Medical Qiyuan": "Healing the heart meridian guest heat, removing irritability, removing the deficiency heat of the Shangjiao, and treating wind." Stagnant and difficult to urinate." 8. Zhu Zhenheng: "Purge the fire of the triple burner, clear the blood in the stomach and stomach, control the heartache caused by heat, relieve heat and stagnation, and promote stagnation of qi." 8. "Compendium": "Treating hematemesis, epistaxis, dysentery, and bleeding , bloody stranguria, injury and blood stasis, and typhoid overwork, fever, headache, hernia, soup and fire injury." ⑩ "Compendium of Materia Medica": "Use raw fire to purify fire, stir-fry black to stop bleeding, stir-fry ginger juice to treat nausea, internal heat use kernels , Exterior heat with skin." ⑾Guangzhou army "commonly used Chinese herbal medicine handbook": "clearing heat and detoxification, cooling blood and purging fire. Treat jaundice hepatitis, broad bean yellow, cold high fever, bacillary dysentery, nephritis edema, epistaxis, mouth sores, mammary glands Inflammation, sore swollen toxin.” Gardenia jasmine also has antimicrobial effect, that is, gardenia water diffuse liquid can inhibit various fungi such as Pseudomonas schlensi, Epidermophyton inguinale, and Epidermophyton rubrum in the test arm Effect, its water decoction 15 mg/ml can kill Leptospira, in vitro, gardenia decoction can stop the activity of schistosomiasis, and the decoction has no inhibitory effect on bacterial growth. Gardenia alcohol extract stimulates the isolated intestinal smooth muscle of rabbits and rats at low concentrations and inhibits at high concentrations. Didhydroxygeniposide has a laxative effect on mice, and its extract can be made into ointment, which can accelerate the healing of soft tissues.
茵陈,【拉丁学名】ArtemisiacapillarisThunb;【别名】绵茵陈、茵陈蒿、白蒿、绒蒿、猴子毛。【性味】苦、辛,微寒。【归经】归脾、胃、肝、胆经。【化学成分】滨蒿含挥发油,油中成分有香芹酮、对-聚伞花素、苎烯、紫苏烯、α-水芹烯、百里香酚、α-、β-蒎烯、松油醇-4、马鞭草酮、萘、芳甲基苯乙酮.另含滨蒿素、对羟基苯乙酮及绿原酸等.菌陈含挥发油,油中成分有月桂烯、苎烯、桉油精、α-蒎烯、莰烯、α-姜黄烯、达瓦酮、茵陈炔酮、丁香酚、异丁香酚、萘、苯甲醛、龙脑.另含茵陈色原酮、6,7-二甲氧基香豆素(即滨蒿素).另据报道,从茵陈蒿地上部分分得茵陈蒿素A、B。【功能主治】清湿热,退黄疸。用于黄疸尿少,湿疮瘙痒;传染性黄疸型肝炎。体外试验证明,茵陈煎剂对金黄色葡萄球菌、白喉杆菌、炭疽杆菌、伤寒杆菌、甲型副伤寒杆菌、绿脓杆菌、大肠杆菌、弗氏痢疾杆菌、志贺氏痢疾杆菌、脑膜炎双球菌、枯草杆菌等有不同程度的抑制作用。10%煎剂能完全抑制人型结核杆菌的生长。1:100的浓度对人型与牛型结核杆菌均有抑制作用。茵陈色原酮体外试验对氯霉素的抗菌作用有拮抗作用。茵陈二炔酮具有较高的抗菌作用,尤其对皮肤病原性丝状菌作用强大,表现为杀菌作用,经长时间100℃以上高温处理,其抗菌力仍不减低。在0.25μg/ml浓度下还能完全阻止猩红色毛癣茵的生长繁殖。滨蒿内酯对鼠角叉菜胶引起的浮肿有抗炎作用。醋酸扭体法和热板法均显示有镇痛作用。茵陈具有促进白细胞分裂,增加白细胞数目,提高T细胞的免疫活性,参与机体的免疫调节和诱生干扰素等作用,因而从多方面提高机体的免疫功能。茵陈中的咖啡酸具有升高白细胞数目、利胆止血、抗生育等作用。口服茵陈250mg/kg可明显增强移植肿瘤小鼠迟发型超敏反应。 Capillaris, [Latin scientific name] ArtemisiacapillarisThunb ; [alias] Mian capillaris, Artemisia capillaris, Artemisia capillaris, Artemisia velvet, monkey hair. [nature and flavor] bitter, pungent, slightly cold. [return through] returns spleen, stomach, liver, gall bladder channel. [Chemical composition] Artemisia basilicum contains volatile oil, and the components in the oil include carvone, p-cymene, limonene, perillene, α-phellandrene, thymol, α-, β-pinene, pine oil Alcohol-4, verbenone, naphthalene, arylmethyl acetophenone. It also contains basin, p-hydroxyacetophenone and chlorogenic acid, etc. Bacteria contains volatile oil, and the oil contains myrcene, limonene, eucalyptus Olein, α-pinene, camphene, α-curcumene, dalvatone, caprinone, eugenol, isoeugenol, naphthalene, benzaldehyde, borneol. Also contains caprene chromone, 6, 7-dimethoxycoumarin (ie, artemisinin). It is also reported that artemisinin A and B can be obtained from the aerial part of Artemisia annua. [functions and indications] clearing damp-heat, reducing jaundice. For jaundice oliguria, eczema itching; infectious jaundice hepatitis. In vitro tests have shown that Yinchen decoction is effective against Staphylococcus aureus, Bacillus diphtheria, Bacillus anthracis, Bacillus typhi, Bacillus paratyphoid A, Pseudomonas aeruginosa, Escherichia coli, Shigella flexneri, Shigella dysenteriae, and meningitis. Cocci, Bacillus subtilis, etc. have different degrees of inhibition. 10% decoction can completely inhibit the growth of Mycobacterium tuberculosis. The concentration of 1:100 has inhibitory effect on human and bovine Mycobacterium tuberculosis. The in vitro test of chromogenone of capillary has antagonistic effect on the antibacterial effect of chloramphenicol. Diynone has a high antibacterial effect, especially for skin pathogenic filamentous bacteria, showing a bactericidal effect. After a long time of high temperature treatment above 100 ℃, its antibacterial effect is still not reduced. At a concentration of 0.25 μg/ml, it can also completely prevent the growth and reproduction of Trichophyton rubrum. Artemisinin has anti-inflammatory effect on edema induced by murine carrageenan. Both the acetic acid writhing method and the hot plate method have been shown to have an analgesic effect. Yinchen can promote the division of white blood cells, increase the number of white blood cells, improve the immune activity of T cells, participate in the immune regulation of the body and induce interferon, thus improving the immune function of the body in many ways. The caffeic acid in capillary can increase the number of white blood cells, promote choleresis and stop bleeding, and have anti-fertility effects. Oral capillary 250mg/kg can significantly enhance the delayed type hypersensitivity of transplanted tumor mice.
大青叶,【拉丁学名】IsatisindigoticaFortune;【别名】蓝腚叶、蓝叶、蓝靛叶、靛青叶、大青;【性味】苦;寒。【归经】肝经;心经;胃经;脾经。【功能主治】清热,解毒,凉血,止血。治温病热盛烦渴,流行性感冒,急性传染性肝炎,菌痢,急性胃肠炎,急性肺炎,丹毒,吐血,衄血,黄疸,痢疾,喉痹,口疮,痈疽肿毒。1、《别录》:“疗时气头痛,大热,口疮。”“蓝叶汁,杀百药毒,解狼毒,射罔毒。”2、陶弘景:“疗伤寒方多用此,除时行热毒为良。“蓝汁,至解毒。以汁涂五心,又止烦闷。甚疗蜂蟹毒。”3、《纲目》:“主热毒痢,黄疸,喉痹,丹毒。”“蓝叶汁,解斑蝥、芫青、樗鸡,朱砂、砒石毒。”4、《本草正》:“治瘟疫热毒发狂,风热斑疹,痈疡肿痛,除烦渴,止鼻衄、吐血,杀疳蚀、金疮箭毒。凡以热兼毒者,皆宜蓝叶捣汁用之。”5、广州部队《常用中草药手册》:"清热泻火,凉血解毒,散瘀止血。治肠炎,菌痢,咽喉炎,扁桃体炎,腮腺炎,感冒发热,齿龈出血。”6、《江西草药》:“治急性肝炎,肺结核,矽肺,牙痛,蛇伤,过敏性皮炎。【药理作用】1、抗病原微生物作用:体外实验表明:大青叶有广谱抗生素作用。其煎剂对金黄色葡萄球菌、甲型链球菌、脑膜炎双球菌、肺炎双球菌、卡他球菌、伤寒杆菌、大肠杆菌、流感杆菌、白喉杆菌及痢疾杆菌均有一定程度的抑制作用。路边青叶煎剂在试管内对多种痢疾杆菌均有杀菌作用;试验还表明:其对合霉素、呋喃西林、磺胺噻唑、小檗碱敏感或耐药的痢疾杆菌,均有良好的抗菌作用。大青叶对乙型脑炎病毒、腮腺炎病毒、流感病毒亦有抑制作用.对钩端螺旋体也有杀灭作用。2、抗炎、解热作用:蓼蓝叶煎剂10g/kg给兔灌服,可抑制二甲苯引起的局部皮肤炎症反应,降低毛细血管通透性。5g/kg灌胃可使大鼠甲醛性脚肿减轻或消退加速。5~10g/kg灌胃,可使霍乱、伤寒混合疫苗引起发热的家兔体温明显下降。 Daqingye, [Latin scientific name] Isatisindigotica Fortune ; [alias] blue scorpion leaf, blue leaf, blue indigo leaf, indigo leaf, Daqing; [nature and flavor] bitter; cold. [return through] Liver Channel; Heart Channel; Stomach Channel; Spleen Channel. [functions and indications] heat-clearing, detoxification, cooling blood, hemostasis. Treat febrile diseases with excessive heat and polydipsia, influenza, acute infectious hepatitis, bacillary dysentery, acute gastroenteritis, acute pneumonia, erysipelas, hematemesis, epistaxis, jaundice, dysentery, sore throat, aphtha, carbuncle and swollen toxin. 1. "Bie Lu": "Treat Shiqi headache, severe fever, aphtha.""Blue leaf juice, kill hundreds of drug poisons, detoxify wolf poison, shoot dead poison." It is good to treat heat and poison in time." Blue juice, to detoxify. Apply the juice to the five hearts to relieve boredom. Very therapeutic bee and crab venom. 3. "Compendium": "Main heat and toxic dysentery, jaundice, sore throat, erysipelas.""" Blue leaf juice, detoxification of mylabris, coriander, jasmine chicken, cinnabar, arsenic stone poison. " 4, " book on Chinese herbal medicine is just ": " controls plague pyretic poison to go mad, wind-heat macule, carbuncle sore swelling and pain, removes polydipsia, stops epistaxis, spits blood, kills malnutrition, golden sore curare." For those who are both hot and poisonous, it is suitable to use blue leaf pounded juice. "5, Guangzhou Army "Common Chinese Herbal Medicine Handbook": "clearing heat and purging fire, cooling blood and detoxification, dissipating blood stasis to stop bleeding." Treat enteritis, bacillary dysentery, pharyngitis, tonsillitis, mumps, cold and fever, bleeding gums. 6. "Jiangxi Herbal Medicine": "Treating acute hepatitis, tuberculosis, silicosis, toothache, snakebite, and allergic dermatitis." [Pharmacological action] 1. Anti-pathogenic microorganism action: in vitro experiments show that Folium Folium has broad-spectrum antibiotic action. Its decoction has a certain degree of inhibitory effect on Staphylococcus aureus, Streptococcus A, Neisseria meningitidis, Streptococcus pneumoniae, catarrhal bacteria, typhoid bacillus, Escherichia coli, influenza bacillus, diphtheria bacillus and Shigella. Roadside Qingye decoction has bactericidal effect on a variety of Shigella in test tubes; the test also shows that it has good antibacterial effect on Shigella sensitive or resistant to synmycin, nitrofurazone, sulfathiazole, and berberine. effect. Daqingye also has inhibitory effect on Japanese encephalitis virus, mumps virus and influenza virus. It also has a killing effect on Leptospira. 2. Anti-inflammatory and antipyretic effects: Polygonum blue leaf decoction 10g/kg fed to rabbits can inhibit local skin inflammation caused by xylene and reduce capillary permeability. 5g/kg intragastric administration can reduce or accelerate the disappearance of formaldehyde-induced foot swelling in rats. Oral administration of 5-10g/kg can significantly reduce the body temperature of rabbits with fever caused by mixed cholera and typhoid vaccines.
山银花,【拉丁学名】FlosLoniceraeConfusae;【别称】山花、南银花、山金银花、土忍冬、土银花;【功效主治】清热解毒,疏散风热。用于痈肿疗疮,喉痹,丹毒,热毒血痢,风热感冒,温热发病。 Flos Lonicerae, [Latin scientific name] FlosLonicerae Confusae ; [Also known as] Flos Lonicerae Confusae, Flos Lonicerae, Flos Lonicerae, Flos Lonicerae, Flos Lonicerae; [Efficacy and Indications] Clearing heat and detoxification, dispelling wind-heat. For carbuncle and swollen sores, sore throat, erysipelas, toxic pyretic blood dysentery, wind-heat cold, and warm-heat disease.
马齿苋,【拉丁学名】PortulacaoleraceaL.;【别称】马苋,五行草,长命菜,五方草,瓜子菜,麻绳菜,马齿菜,蚂蚱菜;每100克马齿苋鲜嫩苋茎叶含蛋白质2.3克,脂肪0.5克,糖类3克,粗纤维0.7克,钙85毫克,磷56毫克,铁1.5毫克,胡萝卜素2.23毫克,维生素BI0.03毫克,维生素E0.11毫克,维生素P0.7毫克,维生素C23毫克。此外,还含有大量去甲肾上腺素、钾盐及丰富的柠檬酸、苹果酸、氨基酸以及生物碱等成分。马齿苋对大肠杆菌、痢疾杆菌、伤寒杆菌等均有较强的抑制作用,特别是对痢疾杆菌的作用很强,所以.马齿菜适宜患有急慢性痢疾肠炎以及膀胱炎,尿道炎(轻度尿道畸形也可)的人服食。马齿苋中含大量去甲肾上腺素和多量钾盐,以及苹果酸、柠檬酸、谷氨酸、天冬氨酸、丙氨酸和蔗糖、葡萄糖、果糖等。现代药理研究表明:抑菌试验:对大肠杆菌、伤寒杆菌、痢疾杆菌等均有抑制作用,特别对痢疾杆菌的作用很强。【药用功效】热毒泻痢;热淋;尿闭;赤白带下;崩漏;痔血;疮疡痈疖;丹毒;瘰疬;湿癣;白秃:痢疾(大便半干半稀)、清热解毒;凉血止血;热毒血痢;痈肿疔疮;湿疹;蛇虫咬伤;便血;崩漏下血;现代大多用于治疗肠炎、急性关节炎、膀胱炎、尿道炎、肛门炎、痔疮出血等。马苋菜全草含丰富的维生素A,能促进上皮细胞的生理功能趋于正常,促进溃疡病的愈合。马苋菜全草对痢疾杆菌、伤寒杆菌有抑制作用,民间常用单味水煎服或取鲜草洗净捣烂,取汁一杯加入少许黄酒治疗痢疾。马苋菜全草对常见致病性皮肤真菌亦有抑制作用,用鲜草洗净捣烂外敷或单味煎洗,或配臭梧桐叶50g煎服,可治疗湿疹,稻田皮灸,还可以治毒蛇咬伤、淋巴结核、急性阑尾炎、痔疮等。另外,马苋菜鲜草VE的含量达0.2%,比菠萝高5倍,有助于人体抗衰老。在皖南地区通常用其焯水晒干后的全株泡发做菜供产后妇女食用,可有利于产后恢复和排出湿气。 Purslane, [Latin scientific name] Portulacaoleracea L.; [alias] purslane, five-element grass, long-lived vegetable, five-party grass, melon seed dish, hemp rope dish, purslane, grasshopper; per 100 grams of purslane Fresh young amaranth stems and leaves contain 2.3 grams of protein, 0.5 grams of fat, 3 grams of sugar, 0.7 grams of crude fiber, 85 mg of calcium, 56 mg of phosphorus, 1.5 mg of iron, 2.23 mg of carotene, 0.03 mg of vitamin BI, and 0.11 mg of vitamin E mg, vitamin P0.7 mg, vitamin C23 mg. In addition, it also contains a large amount of norepinephrine, potassium salt and rich citric acid, malic acid, amino acids and alkaloids. Purslane has a strong inhibitory effect on Escherichia coli, Shigella, typhoid bacillus, etc., especially against Shigella, so. Purslane is suitable for people suffering from acute and chronic dysentery enteritis, cystitis, and urethritis (mild urethral deformity is also acceptable). Purslane contains a lot of norepinephrine and a lot of potassium salts, as well as malic acid, citric acid, glutamic acid, aspartic acid, alanine and sucrose, glucose, fructose and so on. Modern pharmacological studies have shown: antibacterial test: it has inhibitory effects on Escherichia coli, typhoid bacillus, and Shigella, especially against Shigella. [Medicinal effects] heat-toxin diarrhea and dysentery; hot stranguria; anuria; red and white vaginal discharge; uterine bleeding; hemorrhoids and blood; sores and carbuncles; erysipelas; , heat-clearing and detoxifying; cooling blood to stop bleeding; toxic heat and bloody dysentery; carbuncle and furuncle; eczema; snake bites; blood in the stool; Inflammation, bleeding hemorrhoids, etc. The whole herb of horse amaranth is rich in vitamin A, which can promote the physiological function of epithelial cells to normalize and promote the healing of ulcer disease. The whole herb of horse amaranth has inhibitory effect on Shigella and typhoid bacillus. Folks often decoct it in water with a single flavor or wash and mash fresh grass. Take a cup of juice and add a little rice wine to treat dysentery. The whole herb of horse amaranth also has inhibitory effect on common pathogenic skin fungi. Wash it with fresh grass and mash it for external application or decoct it with a single flavor, or decoct it with 50g of stinky phoenix leaves. It can treat eczema, rice field skin moxibustion, and cure Venomous snake bites, lymphatic tuberculosis, acute appendicitis, hemorrhoids, etc. In addition, the content of VE in the fresh grass of amaranth is 0.2%, which is 5 times higher than that of pineapple, which helps the human body to resist aging. In southern Anhui, the blanched and sun-dried whole plant is usually soaked in hair for cooking for postpartum women, which can help postpartum recovery and discharge moisture.
赤芍,学名:RADIXPAEONIAERUBRA【别名】木芍药、草芍药、红芍药、毛果赤芍,为毛茛科植物芍药PaeonialactifloraPall.或川赤芍PaeoniaveitchiiLynch的干燥根。【功效】清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。【主治】用于热人营血,温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,瘾瘕腹痛,跌扑损伤,痈肿疮疡。 Radix Paeoniae Rubra, scientific name: RADIXPAEONIAERUBRA [alias] Radix Paeoniae Rubra, Grass Radix Paeoniae Rubra, Radix Paeoniae Rubra, Radix Paeoniae Rubra, is the dried root of Paeonia actiflora Pall. or Paeoniaveitchii Lynch. [Efficacy] Clearing heat and cooling blood, dissipating blood stasis and relieving pain. It is used for warming and poisoning spots, vomiting blood and epistaxis, conjunctival congestion and swelling pain, liver depression and hypochondriac pain, amenorrhea dysmenorrhea, abdominal pain in the abdomen, injury from falls, carbuncle sores. [Indications] It is used for warming human blood, warming and poisoning spots, vomiting blood and epistaxis, conjunctival congestion, swelling and pain, liver depression and hypochondriac pain, amenorrhea dysmenorrhea, abdominal pain due to addiction, injury from falls, carbuncle and sore.
丹皮,为毛茛科多年生落叶小灌木植物牡丹PaeoniasuffruticosaAndr.的干燥根皮。【性味归经】性寒,味苦;凉;微寒。归心;肝;肾;肺经。味苦、辛,微寒。归心、肝、肾经。【功效主治】清热凉血;活血散瘀。温热病热入血分;发斑;吐衄;热泪盈眶病菌后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹。《本草纲目》:“滋阴降火,解斑毒,利咽喉,通小便血滞。后人乃专以黄蘖治相火,不知丹皮之功更胜也。赤花者利,白花者补,人亦罕悟,宜分别之。”现代研究,所含牡丹酚及其以外的糖苷类成分均有抗炎作用;牡丹皮的甲醇提取物有抑制血小板作用;牡丹酚有镇静、降温、解热、镇痛、解痉等中枢抑制作用及抗动脉粥样硬化、利尿、抗溃疡等作用。体外实验表明,牡丹皮煎剂对枯草杆菌、大肠杆菌、伤寒杆菌、副伤寒杆菌、变形杆菌、绿脓杆菌、葡萄球菌、溶血性链球菌、肺炎球菌、霍乱弧菌等均有较强的抗菌作用,牡丹叶煎剂对痢疾杆菌、绿脓杆菌和金黄色葡萄球菌有显著抗菌作用,其有效成份为没食子酸。给小鼠分别灌胃牡丹皮,丹皮酚、芍药甙、氧化芍药甙、苯甲酰芍药甙,均能促进静脉注射的碳粒在血中的廓清速度,即使单核巨噬细胞系统功能处于低下状态也有促进作用,显微镜检查见肝中枯氏细胞及脾中巨噬细胞吞噬力增强。芍药甙、氧化芍药甙在体外亦能增强小鼠腹腔巨噬细胞对乳液的吞噬功能。丹皮液给小鼠腹腔注射能使其脾脏溶血后斑数增加。用丹皮酚给小鼠腹腔注射每天25mg/kg,连用6天,能使脾重明显增加,且可对抗考的松、环磷酰胺所致胸腺重量的减轻。由上可见牡丹皮对体液及细胞免疫均有增强作用。用丹皮酚灌胃,对大鼠因右旋糖酐或醋酸或角叉菜胶引起的足跖浮肿有抑制作用,并能抑制醋酸或5-羟色胺引起的小鼠腹腔或豚鼠皮肤毛细血管通透性增强,抑制小鼠应激性溃疡的发生。 Danpi is the dry root bark of Paeoniasuffruticosa Andr. , a perennial deciduous shrub of the family Ranunculaceae. [meridian distribution of nature and flavor] cold in nature, bitter in taste; cool; slightly cold. Guixin; Liver; Kidney; Lung Channel. Bitter, pungent, slightly cold. GUIXIN, liver, kidney channel. [Efficacy and Indications] Clearing away heat and cooling blood; promoting blood circulation and dispelling stasis. Warm febrile disease with heat entering the blood system; spotting; vomiting of nosebleeds; hot tears filling the eyes and causing fever in the late stage of pathogenic bacteria; yin deficiency and bone steaming and hot flashes; blood stagnation and amenorrhea; dysmenorrhea; carbuncle sores; tumbling pain; rheumatism heat paralysis. "Compendium of Materia Medica": "Nourishing yin and reducing fire, detoxifying spot poisoning, benefiting throat, clearing blood stagnation in urination. Later generations use yellow tiller to treat phase fire, but they don't know that the power of paeonol is better. The red flower is beneficial, and the white flower is nourishing. , People are also rarely realized, so it is advisable to distinguish them." Modern research shows that the contained paeonol and other glycoside components have anti-inflammatory effects; the methanol extract of Moutan cortex has the effect of inhibiting platelets; Heat, analgesic, antispasmodic and other central inhibitory effects and anti-atherosclerosis, diuretic, anti-ulcer effects. In vitro experiments show that Moutan cortex decoction has strong antibacterial effect on Bacillus subtilis, Escherichia coli, Bacillus typhi, Bacillus paratyphi, Proteus, Pseudomonas aeruginosa, Staphylococcus, hemolytic streptococcus, pneumococcus, Vibrio cholerae, etc. Effect, peony leaf decoction has significant antibacterial effect on Shigella, Pseudomonas aeruginosa and Staphylococcus aureus, and its active ingredient is gallic acid. Moutan cortex, paeonol, paeoniflorin, oxidized paeoniflorin, and benzoylpaeoniflorin were administered to mice respectively, all of which could promote the clearance of intravenously injected carbon particles in the blood, even if the mononuclear macrophage system function was at The low state also has a promoting effect. Microscopic examination shows that the phagocytosis of Kupffer cells in the liver and macrophages in the spleen is enhanced. Paeoniflorin and oxidized paeoniflorin can also enhance the phagocytosis of mouse peritoneal macrophages to emulsion in vitro. Intraperitoneal injection of paeonol solution to mice can increase the number of plaques in the spleen after hemolysis. Intraperitoneal injection of paeonol to mice at 25 mg/kg per day for 6 consecutive days can significantly increase the spleen weight, and can resist the reduction of thymus weight caused by cortisone and cyclophosphamide. It can be seen from the above that Cortex Moutan can enhance both humoral and cellular immunity. Intragastric administration of paeonol can inhibit paw edema in rats caused by dextran, acetic acid or carrageenan, and can inhibit the increase of capillary permeability in mouse abdominal cavity or guinea pig skin caused by acetic acid or 5-hydroxytryptamine , Inhibit the occurrence of stress ulcer in mice.
麦芽,为禾本科植物大麦HordeumvulgareL.的成熟果实经发芽干燥而得。【拉丁学名】FructusHordeiGerminatus【别名】大麦糵、大麦毛、大麦芽、生麦芽、大麦蘖、麦蘖、炒麦芽、焦麦芽、麦糵。【性味】甘;平【归经】脾经;胃经。【功能主治】行气消食,健脾开胃,退乳消胀。用于食积不消,脘腹胀痛,脾虚食少,乳汁郁积,乳房胀痛,妇女断乳。麦芽所含的大麦碱A和B有抗真菌活性。 Malt is obtained by germination and drying of the mature fruit of the gramineous plant barley Hordeumvulgare L. [Latin scientific name] FructusHordeiGerminatus [alias] barley grits, barley wool, barley malt, raw malt, barley tiller, wheat tiller, fried malt, burnt malt, barley glutinous rice flour. [nature and flavor] sweet; flat [return through] spleen meridian; stomach meridian. [Functions and Indications] Promoting qi and eliminating food, invigorating the spleen and appetizing, reducing breast milk and reducing swelling. Used for indigestion, distending pain in the abdomen, lack of appetite due to spleen deficiency, stagnant milk, breast distending pain, and women weaning. Barley alkaloids A and B contained in malt have antifungal activity.
所述的可溶性辅料为糊精、可溶性淀粉或乳糖中的任何一种。 The soluble auxiliary material is any one of dextrin, soluble starch or lactose.
提高养殖对虾存活率的中药制剂的制备方法,包括如下步骤: A preparation method of a traditional Chinese medicine preparation for improving the survival rate of cultured prawns, comprising the steps of:
(1)原料前处理:把火炭母、山栀子、大青叶、马齿苋、赤芍和丹皮粉碎成40-60目,与茵陈、山银花、麦芽混合,80-100目滤布袋包裹; (1) Pre-treatment of raw materials: crush the mother of charcoal, jasmine jasmine, Folium oleracea, purslane, red peony root and paeonol into 40-60 mesh, mix with capillary, mountain silver flower, malt, 80-100 mesh filter bag wrapping;
(2)活性物质的提取:将步骤(1)装有混合药细粒的滤布袋,加20倍量水,多功能提取罐回流提取2次,每次沸腾30分钟,300-500目滤布过滤,合并滤液; (2) Extraction of active substances: Add 20 times the amount of water to the filter cloth bag containing the mixed medicine fine particles in step (1), reflux and extract the multifunctional extraction tank twice, boil for 30 minutes each time, filter cloth with 300-500 mesh Filter and combine the filtrates;
(3)减压浓缩:将步骤(2)的滤液用单效外循环锅减压浓缩,至70-80℃时相对密度为1.10-1.30的浓缩药液; (3) Concentration under reduced pressure: Concentrate the filtrate in step (2) under reduced pressure in a single-effect external circulation pot until it reaches a concentrated medicinal solution with a relative density of 1.10-1.30 at 70-80°C;
(4)添加辅料:加入可溶性辅料,拌匀,使辅料充分溶解,使药辅高度混合均匀; (4) Add excipients: add soluble excipients and mix well to fully dissolve the excipients and make the excipients highly mixed evenly;
(5)瞬间干燥:采用喷雾干燥的方法,于210-220℃将药辅混合液瞬间干燥; (5) Instant drying: use the method of spray drying to dry the medicine-aid mixture at 210-220°C;
(6)中间体质量检查:检测活性成分的含量、溶化性及制剂微生物; (6) Quality inspection of intermediates: testing the content, solubility and preparation microorganisms of active ingredients;
(7)分装:按200g/瓶分装于聚乙烯塑料瓶中,电磁波热封内盖。 (7) Packing: 200g/bottle is packed in polyethylene plastic bottles, and the inner cap is heat-sealed with electromagnetic waves.
本中药制剂使用方法:按药粉与饲料的百分比为2%~10%混拌于饲料中投喂对虾,每天1~2次,连续3~7天为一周期。 The method of use of this traditional Chinese medicine preparation: according to the percentage of the medicine powder and the feed is 2% ~ 10%, mix and mix in the feed and feed the prawns, 1 ~ 2 times a day, 3 ~ 7 consecutive days as a cycle.
本发明的有益效果是: The beneficial effects of the present invention are:
1、通过在饲料中加入以火炭母、山栀子、茵陈、大青叶、山银花、马齿苋、赤芍、丹皮和麦芽为原料经现代制药技术加工而成的中草药添加剂,具有清热利湿,解毒护肝,健胃消食的功效,经过发明人分别用玻璃虾缸和水泥池两种规格的养殖环境,开展试药组(本发明生产得到的提高养殖对虾存活率的中药制剂,发明人将该中药制剂命名为“试药组”)对南美白对虾存活、生长及水体氨氮影响实验,科学养殖实验表明,能够显著提高南美白对虾的存活率,使用后最高的南美白对虾养殖成活率可以达到98%,显著促进南美白对虾生长,同时还能显著降低水体的氨氮值。更重要的是,中草药不会给对虾及饲养环境带来副作用,且本发明的中草药原料价格便宜,简单易得。 1. By adding Chinese herbal medicine additives processed by modern pharmaceutical technology, which are made of fotanmu, gardenia, capillary, Folium Isatidis, mountain silver flower, purslane, red peony root, paeonol and malt as raw materials, It has the effects of clearing away heat and promoting dampness, detoxifying and protecting the liver, invigorating the stomach and eliminating food. After the inventor uses the breeding environment of two specifications of the glass shrimp tank and the cement pond respectively, a test group (the traditional Chinese medicine for improving the survival rate of cultured prawns produced by the present invention) is carried out. The inventor named the traditional Chinese medicine preparation as "test drug group") on the survival and growth of Penaeus vannamei and the influence of ammonia nitrogen in the water body. Scientific breeding experiments showed that it can significantly improve the survival rate of Penaeus vannamei. After use, the highest vannamei The survival rate of prawn farming can reach 98%, which can significantly promote the growth of Penaeus vannamei, and can also significantly reduce the ammonia nitrogen value of the water body. More importantly, the Chinese herbal medicine will not bring side effects to the prawns and the feeding environment, and the raw materials of the Chinese herbal medicine of the present invention are cheap and easy to obtain.
2、本发明研制的中药制剂,还具有抗病菌、抗病毒、提高免疫功能、提高机体抗病能力等作用,并且对养殖水体无污染。 2. The traditional Chinese medicine preparation developed by the present invention also has the effects of anti-bacteria, anti-virus, improving immune function, improving the body's disease resistance, and has no pollution to aquaculture water.
3、发明人还开展了试药组(本发明生产得到的提高养殖对虾存活率的中药制剂,发明人将该中药制剂命名为“试药组”)治疗南美白对虾肝、胃、肠疾病的疗效观察试验,试验结果提示试药组治疗南美白对虾的肝、胃、肠疾病,有明显疗效。 3. The inventor has also carried out a test drug group (the traditional Chinese medicine preparation produced by the present invention to improve the survival rate of cultured prawns, the inventor named the Chinese medicine preparation "test drug group") to treat the liver, stomach and intestinal diseases of Penaeus vannamei The curative effect observation test showed that the test drug group had obvious curative effect on the liver, stomach and intestinal diseases of Penaeus vannamei.
具体实施方式 detailed description
实施例1 Example 1
提高养殖对虾存活率的中药制剂,包括以下重量份数的中药组分: The traditional Chinese medicine preparation for improving the survival rate of cultured prawns comprises the following traditional Chinese medicine components in parts by weight:
火炭母:30份;山栀子:20份;茵陈:20份;大青叶:15份;山银花:15份;马齿苋:15份;赤芍:20份;丹皮:20份;麦芽:20份;糊精:35份。 Fotan mother: 30 parts; Gardenia: 20 parts; Capillary: 20 parts; Daqingye: 15 parts; Mountain silver flower: 15 parts; parts; malt: 20 parts; dextrin: 35 parts.
提高养殖对虾存活率的中药制剂的制备方法,包括如下步骤: A preparation method of a traditional Chinese medicine preparation for improving the survival rate of cultured prawns, comprising the steps of:
(1)原料前处理:把30份火炭母、30份20份山栀子、15份大青叶、15份马齿苋、20份赤芍和20份丹皮粉碎成40目,与20份茵陈、15份山银花、20份麦芽混合,80目滤布袋包裹; (1) Pre-treatment of raw materials: crush 30 parts of Fotanmu, 30 parts of 20 parts of gardenia, 15 parts of Folium oleracea, 15 parts of purslane, 20 parts of red peony and 20 parts of paeonol into 40 meshes, and 20 parts of Yinchen, 15 parts of mountain silver flower, 20 parts of malt, wrapped in 80-mesh filter bag;
(2)活性物质的提取:将装有混合药细粒的滤布袋,加20倍量水,多功能提取罐回流提取2次,每次沸腾30分钟,300目滤布过滤,合并滤液; (2) Extraction of active substances: add 20 times the amount of water to the filter cloth bag containing the fine particles of the mixed medicine, reflux and extract twice in the multifunctional extraction tank, boil for 30 minutes each time, filter with a 300-mesh filter cloth, and combine the filtrates;
(3)减压浓缩:将上述滤液用单效外循环锅减压浓缩,至70℃时相对密度为1.10的浓缩药液; (3) Concentration under reduced pressure: Concentrate the above-mentioned filtrate under reduced pressure in a single-effect external circulation pot to a concentrated medicinal solution with a relative density of 1.10 at 70°C;
(4)添加辅料:加入35份糊精,拌匀,使辅料充分溶解,使药辅高度混合均匀; (4) Add excipients: Add 35 parts of dextrin and mix well to fully dissolve the excipients and make the excipients highly mixed evenly;
(5)瞬间干燥:采用喷雾干燥的方法,于210℃将药辅混合液瞬间干燥; (5) Instant drying: use the method of spray drying to dry the medicine-aid mixture at 210°C;
(6)中间体质量检查:检测活性成分的含量、溶化性及制剂微生物; (6) Quality inspection of intermediates: testing the content, solubility and preparation microorganisms of active ingredients;
(7)分装:按200g/瓶分装于聚乙烯塑料瓶中,电磁波热封内盖。 (7) Packing: 200g/bottle is packed in polyethylene plastic bottles, and the inner cap is heat-sealed with electromagnetic waves.
使用方法:本中药制剂使用方法:按药粉与饲料的百分比为2%混拌于饲料中投喂对虾,每天1~2次,连续3~7天为一周期。 Method of use: The method of use of this traditional Chinese medicine preparation: according to the percentage of the medicine powder and the feed is 2%, mix and mix in the feed and feed the prawns, 1-2 times a day, and a cycle of 3-7 days in a row.
实施例2 Example 2
提高养殖对虾存活率的中药制剂,包括以下重量份数的中药组分: The traditional Chinese medicine preparation for improving the survival rate of cultured prawns comprises the following traditional Chinese medicine components in parts by weight:
火炭母:35份;山栀子:25份;茵陈:25份;大青叶:20份;山银花:20份;马齿苋:20份;赤芍:25份;丹皮:25份;麦芽:25份;可溶性淀粉:40份。 Fotan mother: 35 parts; Gardenia: 25 parts; Capillary: 25 parts; Daqingye: 20 parts; Mountain silver flower: 20 parts; parts; malt: 25 parts; soluble starch: 40 parts.
提高养殖对虾存活率的中药制剂的制备方法,包括如下步骤: A preparation method of a traditional Chinese medicine preparation for improving the survival rate of cultured prawns, comprising the steps of:
(1)原料前处理:把35份火炭母、35份25份山栀子、20份大青叶、20份马齿苋、25份赤芍和25份丹皮粉碎成50目,与25份茵陈、20份山银花、25份麦芽混合,100目滤布袋包裹; (1) Raw material pretreatment: crush 35 parts of Fotanmu, 35 parts of 25 parts of Gardenia, 20 parts of Folium Isatidis, 20 parts of Purslane, 25 parts of Radix Paeoniae Rubra and 25 parts of Dan Cortex into 50 meshes, and mix with 25 parts of Capsicum chen, 20 parts mountain silver flower, 25 parts malt mixed, wrapped in 100 mesh filter bag;
(2)活性物质的提取:将装有混合药细粒的滤布袋,加20倍量水,多功能提取罐回流提取2次,每次沸腾30分钟,500目滤布过滤,合并滤液; (2) Extraction of active substances: Add 20 times the amount of water to the filter cloth bag containing the mixed drug fine particles, reflux and extract twice in the multifunctional extraction tank, boil for 30 minutes each time, filter with a 500-mesh filter cloth, and combine the filtrates;
(3)减压浓缩:将上述滤液用单效外循环锅减压浓缩,至75℃时相对密度为1.20的浓缩药液; (3) Concentration under reduced pressure: Concentrate the above-mentioned filtrate under reduced pressure in a single-effect external circulation pot, and reach a concentrated medicinal solution with a relative density of 1.20 at 75°C;
(4)添加辅料:加入40份可溶性淀粉,拌匀,使辅料充分溶解,使药辅高度混合均匀; (4) Add excipients: Add 40 parts of soluble starch and mix well to fully dissolve the excipients and make the excipients highly mixed evenly;
(5)瞬间干燥:采用喷雾干燥的方法,于215℃将药辅混合液瞬间干燥; (5) Instant drying: use the method of spray drying to dry the medicine-aid mixture at 215°C;
(6)中间体质量检查:检测活性成分的含量、溶化性及制剂微生物; (6) Quality inspection of intermediates: testing the content, solubility and preparation microorganisms of active ingredients;
(7)分装:按200g/瓶分装于聚乙烯塑料瓶中,电磁波热封内盖。 (7) Packing: 200g/bottle is packed in polyethylene plastic bottles, and the inner cap is heat-sealed with electromagnetic waves.
本中药制剂使用方法:按药粉与饲料的百分比为6%混拌于饲料中投喂对虾,每天1~2次,连续3~7天为一周期。 The method of use of this traditional Chinese medicine preparation: according to the percentage of the medicine powder and the feed is 6%, mix it with the prawns in the feed, 1-2 times a day, and a cycle of 3-7 consecutive days.
实施例3 Example 3
提高养殖对虾存活率的中药制剂,包括以下重量份数的中药组分: The traditional Chinese medicine preparation for improving the survival rate of cultured prawns comprises the following traditional Chinese medicine components in parts by weight:
火炭母:40份;山栀子:30份;茵陈:30份;大青叶:25份;山银花:25份;马齿苋:25份;赤芍:30份;丹皮:30份;麦芽:30份;乳糖:45份。 Fotan mother: 40 parts; Gardenia: 30 parts; Capillary: 30 parts; Daqingye: 25 parts; Mountain silver flower: 25 parts; parts; malt: 30 parts; lactose: 45 parts.
提高养殖对虾存活率的中药制剂的制备方法,包括如下步骤: A preparation method of a traditional Chinese medicine preparation for improving the survival rate of cultured prawns, comprising the steps of:
(1)原料前处理:把40份火炭母、40份30份山栀子、25份大青叶、25份马齿苋、30份赤芍和30份丹皮粉碎成60目,与30份茵陈、25份山银花、30份麦芽混合,100目滤布袋包裹; (1) Pretreatment of raw materials: crush 40 parts of Fotanmu, 40 parts of 30 parts of Gardenia, 25 parts of Folium Isatidis, 25 parts of Purslane, 30 parts of Radix Paeoniae Rubra and 30 parts of Dan Cortex into 60 meshes, and mix with 30 parts of Yinchen, 25 parts of mountain silver flower, 30 parts of malt, wrapped in a 100-mesh filter bag;
(2)活性物质的提取:将装有混合药细粒的滤布袋,加20倍量水,多功能提取罐回流提取2次,每次沸腾30分钟,350目滤布过滤,合并滤液; (2) Extraction of active substances: Add 20 times the amount of water to the filter cloth bag containing the fine particles of the mixed medicine, reflux and extract twice in the multifunctional extraction tank, boil for 30 minutes each time, filter through a 350-mesh filter cloth, and combine the filtrates;
(3)减压浓缩:将上述滤液用单效外循环锅减压浓缩,至80℃时相对密度为1.30的浓缩药液; (3) Concentration under reduced pressure: Concentrate the above-mentioned filtrate under reduced pressure in a single-effect external circulation pot to a concentrated medicinal solution with a relative density of 1.30 at 80°C;
(4)添加辅料:加入45份乳糖,拌匀,使辅料充分溶解,使药辅高度混合均匀; (4) Add excipients: Add 45 parts of lactose, mix well, fully dissolve the excipients, and make the excipients highly mixed evenly;
(5)瞬间干燥:采用喷雾干燥的方法,于220℃将药辅混合液瞬间干燥; (5) Instant drying: use the method of spray drying to dry the medicine-aid mixture at 220°C;
(6)中间体质量检查:检测活性成分的含量、溶化性及制剂微生物; (6) Quality inspection of intermediates: testing the content, solubility and preparation microorganisms of active ingredients;
(7)分装:按200g/瓶分装于聚乙烯塑料瓶中,电磁波热封内盖。 (7) Packing: 200g/bottle is packed in polyethylene plastic bottles, and the inner cap is heat-sealed with electromagnetic waves.
本中药制剂使用方法:按药粉与饲料的百分比为10%混拌于饲料中投喂对虾,每天1~2次,连续3~7天为一周期。 The method of use of this traditional Chinese medicine preparation: according to the percentage of the medicine powder and the feed is 10%, mix it with the prawns in the feed, 1-2 times a day, and a cycle of 3-7 consecutive days.
本发明的药效学试验:Pharmacodynamics test of the present invention:
发明人分别用玻璃虾缸和水泥池两种规格的养殖环境,开展试药组(本发明生产得到的提高养殖对虾存活率的中药制剂,发明人将该中药制剂命名为“试药组”)对南美白对虾存活、生长及水体氨氮影响实验。 The inventor used the culture environments of glass shrimp tanks and cement ponds respectively to carry out the test drug group (the traditional Chinese medicine preparation produced by the present invention to improve the survival rate of cultured prawns, the inventor named the Chinese medicine preparation "test drug group") Experiments on the survival and growth of Penaeus vannamei and the effects of ammonia nitrogen in water.
材料与方法Materials and Methods
1.1试验材料1.1 Test material
虾苗:体色鲜艳、健康有活力、无外伤、规格整齐,试水12h后无异常,购于合浦虾苗场。 Shrimp seedlings: bright in color, healthy and vigorous, without trauma, neat in size, no abnormality after 12 hours of water testing, purchased from Hepu shrimp seedling farm.
饲料:为湛江科源饲料有限公司出品。 Feed: Produced by Zhanjiang Keyuan Feed Co., Ltd.
玻璃虾缸:规格为40cm×50cm×50cm,底部配有排水口。 Glass shrimp tank: The size is 40cm×50cm×50cm, with a drain at the bottom.
水泥池:规格为1m×1m×2m,底部设有排水口。 Cement pool: The specification is 1m×1m×2m, with a drain at the bottom.
水源:蓄水池中的消毒新鲜海水。 Water source: Sterilized fresh seawater in the cistern.
试药组:本发明生产得到的提高养殖对虾存活率的中药制剂。 Reagent group: the traditional Chinese medicine preparation produced by the present invention to improve the survival rate of cultured prawns.
中药阳性药:对虾复活丹,由黄莲、黄芩、黄柏、枙子等组成的面市制剂。 Positive medicine of traditional Chinese medicine: Shrimp Fuxing Dan, a marketed preparation composed of Huanglian, Scutellaria, Cortex Phellodendron, and Zongzi.
试验方法experiment method
实验于2015年9月15日-2015年10月23日在课题组南美白对虾养殖基地进行。分玻璃虾缸和水泥池两类实验组。 The experiment was carried out from September 15, 2015 to October 23, 2015 at the Penaeus vannamei breeding base of the research group. There are two types of experimental groups: glass shrimp tanks and cement pools.
玻璃虾缸组:选取出苗20天体长为3±0.5cm的虾苗150尾,用规格为80cm×60cm×50cm玻璃虾缸,缸底部配有排水口,以消毒海水养殖,每天换排缸底水的20%,分3个实验组:空白组、中药阳性组、试药组。每组投虾苗50尾,空白组不给药,按常规喂饲料,一日3餐;给药组(中药阳性组、试药组)将试药组拌喂于饲料中投喂,每日1次,按连续给药3日,停药2日为一个周期,给药6个周期后,逐缸清点南美白对虾数,并每缸随机抽12只对虾,逐只称重,同时测每缸水体中的氨氮。 Glass shrimp tank group: Select 150 shrimp seedlings with a body length of 3±0.5cm after 20 days of emergence, and use a glass shrimp tank with a size of 80cm×60cm×50cm. The bottom of the tank is equipped with a drain port to disinfect the seawater. The bottom of the tank is replaced every day 20% of water, divided into 3 experimental groups: blank group, Chinese medicine positive group, test drug group. 50 shrimp seedlings were thrown into each group, and the blank group was not given medication, and the feed was fed as usual, with 3 meals a day; the drug administration group (Chinese medicine positive group, test drug group) mixed the test drug group in the feed and fed, daily 1 time, 3 consecutive days of administration and 2 days of withdrawal as a cycle. After 6 cycles of administration, count the number of Penaeus vannamei one by one, and randomly select 12 prawns from each tank, weigh each one, and measure each shrimp at the same time. Ammonia nitrogen in tank water.
水泥池组:选取出苗20天体长为3±0.5cm的虾苗300尾,用规格为1m×1m×2m水泥池,池底部设有排水口,以消毒海水养殖,每天换排池底水的20%,分3个实验组:空白组、中药阳性组、试药组。每组投虾苗100尾。空白组不给药,按常规喂饲料,一日3餐;给药组(中药阳性组、试药组)将药拌喂于饲料中投喂,每日1次,按连续给药3日,停药2日为一个周期,给药8个周期后,逐池清点南美白对虾数,并每缸随机抽12只对虾,逐只称重,同时测各池水体中的氨氮。 Cement pool group: Select 300 shrimp seedlings with a body length of 3 ± 0.5cm after 20 days of emergence, use a cement pool with a size of 1m × 1m × 2m, and a drain port is provided at the bottom of the pool to sterilize mariculture, and change the water at the bottom of the pool every day 20%, divided into 3 experimental groups: blank group, positive Chinese medicine group, test drug group. Each group threw 100 shrimp fry. The blank group was not administered, and was fed with feed as usual, 3 meals a day; the drug group (Chinese medicine positive group, test drug group) was fed with the medicine mixed in the feed, once a day, and administered continuously for 3 days, Two days of drug withdrawal constituted a cycle. After 8 cycles of drug administration, the number of Penaeus vannamei was counted pool by pool, and 12 prawns were randomly selected from each tank, weighed one by one, and the ammonia nitrogen in each pool was measured at the same time.
数据统计分析Data Statistical Analysis
计数资料,以±s表示,两组间差异用t检验,数据处理采用SPSSStatistics17.0进行多重比较,P<0.05为差异显著,P<0.01为差异极显著。 Enumeration data, expressed in ±s, the difference between the two groups was tested by t test, and data processing was carried out by SPSS Statistics 17.0 for multiple comparisons. P<0.05 indicated significant difference, and P<0.01 indicated extremely significant difference.
计量资料,以χ2(2×2)法---两组阳性率的统计分析,用以下公式计算x2, For measurement data, use the χ 2 (2×2) method---statistical analysis of the positive rates of the two groups, and use the following formula to calculate x 2 ,
当χ2>6.635时,P<0.01;当χ2>3.841时,P<0.05;当χ2<3.841时,P>0.05。P<0.05为差异显著,P<0.01为差异极显著。 When χ 2 >6.635, P<0.01; when χ 2 >3.841, P<0.05; when χ 2 <3.841, P>0.05. P<0.05 means significant difference, P<0.01 means extremely significant difference.
实验结果Experimental results
表1为玻璃虾缸各组南美白对虾存活数、存活率与体重结果,结果显示:玻璃虾缸实验组中,与空白组比较,试药组的存活率与体重值,均极显著提高(P<0.01);与阳性组比较,无显著性差异(P>0.05)。 Table 1 shows the survival number, survival rate and body weight of Penaeus vannamei in each group of glass shrimp tanks. The results show that: in the glass shrimp tank experimental group, compared with the blank group, the survival rate and body weight of the test group were significantly improved ( P<0.01); compared with the positive group, there was no significant difference (P>0.05).
表2为玻璃虾缸各组水体的氨氮测定结果,结果显示:玻璃虾缸实验组中,空白组、阳性组、试药组组的水体氨氮值均超过标准限度值0.15mg/L,超限值的大小顺序为:阳性组>空白组>试药组结果提示试药组制剂能降低水体的氨氮值,而阳性组却不能降低水体的氨氮值。 Table 2 shows the measurement results of ammonia nitrogen in each group of glass shrimp tanks. The results show that in the glass shrimp tank experimental group, the ammonia nitrogen values in the blank group, the positive group and the test drug group all exceeded the standard limit value of 0.15mg/L, exceeding the limit. The order of the values is: positive group>blank group>test drug group. The results suggest that the test drug group preparation can reduce the ammonia nitrogen value of the water body, but the positive group cannot reduce the ammonia nitrogen value of the water body.
表3为水泥池各组南美白对虾存活数、存活率与体重的结果,结果显示:水泥池实验组中,与空白组比较,试药组的存活率极显著提高(P<0.01),体重显著提高(P<0.05);与阳性组比较,试药组的存活率无显著差异,但其体重显著提高(P<0.05)。 Table 3 shows the results of the survival number, survival rate and body weight of Penaeus vannamei in each group of cement ponds. The results show that: in the cement pond experimental group, compared with the blank group, the survival rate of the test group was significantly increased (P<0.01), and the body weight Significantly increased (P<0.05); compared with the positive group, the survival rate of the test group had no significant difference, but its body weight increased significantly (P<0.05).
表4为水泥池各组水体的氨氮值,与空白组、阳性组比较,试药组组的水体氨氮均显著降低(P<0.05)。 Table 4 shows the ammonia nitrogen value of each group of water in the cement pool. Compared with the blank group and the positive group, the ammonia nitrogen of the water in the test group was significantly reduced (P<0.05).
注:与空白组比较,*P<0.05;与阳性组比,#P<0.05。 Note: Compared with the blank group, * P<0.05; compared with the positive group, # P<0.05.
小结与讨论Summary and Discussion
在玻璃虾缸实验组与水泥池实验组中,与空白组比较,试药组的存活率分别提高28%和18%,均为极有显著差异((P<0.01)。表明试药组对南美白对虾存活的影响极显著,能显著提高南美白对虾的存活率。 In the glass shrimp tank experimental group and the cement pool experimental group, compared with the blank group, the survival rate of the test drug group increased by 28% and 18% respectively, all of which were very significantly different ((P<0.01). The impact on the survival of Penaeus vannamei is extremely significant, and can significantly improve the survival rate of Penaeus vannamei.
与空白组比较,玻璃虾缸中的试药组组体重极显著提高((P<0.01),水泥池的试药组组体重显著提高((P<0.05);而且,水泥池的试药组组体重比阳性组体重显著提高(P<0.05)。表明试药组对南美白对虾的生长有极显著的促进作用。通过对各组水体氨氮的测定,氨氮值从大到小的顺序表明,试药组能显著降低水体的氨氮值。 Compared with the blank group, the body weight of the test group in the glass shrimp tank was significantly increased ((P<0.01), and the body weight of the test group in the cement pool was significantly increased ((P<0.05); moreover, the test group in the cement pool The body weight of the group is significantly improved (P<0.05) than the positive group. Show that the test group has a very significant promotion effect on the growth of Penaeus vannamei. By measuring the ammonia nitrogen in each group of water bodies, the order of ammonia nitrogen values from large to small shows that, The test group can significantly reduce the ammonia nitrogen value of the water body.
在南美白对虾养殖过程中,对其存活与生长的影响因素很多,比如气候变化、常见疾病、水体质量、药物干预等等,本发明从药物干预角度出发,研制具有清热利湿,解毒护肝,健胃消食的中药新制剂试药组,分别用玻璃缸小水体和水泥池中等水体开展实验,考察试药组对南美白对虾的存活、生长的影响,同时也考察其对水体氮氨的影响,结果表明,试药组极显著提高南美白对虾的存活率,使用后最高的南美白对虾养殖成活率可以达到98%,显著促进对虾的生长,同时显著降低水体的氨氮。 During the breeding process of Penaeus vannamei, there are many factors that affect its survival and growth, such as climate change, common diseases, water quality, drug intervention, etc. The present invention, from the perspective of drug intervention, develops a medicinal product with the functions of clearing away heat and promoting dampness, detoxifying and protecting the liver. , the test group of the new preparation of traditional Chinese medicine for invigorating the stomach and eliminating food, carried out experiments with the small water body of the glass tank and the medium water body of the cement pool respectively, and investigated the effect of the test group on the survival and growth of Penaeus vannamei, and also investigated its effect on nitrogen and ammonia in the water body. The results showed that the test group significantly improved the survival rate of Penaeus vannamei, and the highest survival rate of Penaeus vannamei after use could reach 98%, which significantly promoted the growth of prawns and significantly reduced the ammonia nitrogen in the water body.
发明人还开展了试药组(本发明生产得到的提高养殖对虾存活率的中药制剂,发明人将该中药制剂命名为“试药组”)治疗南美白对虾肝、胃、肠疾病的疗效观察试验。 The inventor also carried out the observation of the curative effect of the experimental group (the traditional Chinese medicine preparation produced by the present invention to improve the survival rate of cultured prawns, which the inventor named as "the experimental group") to treat the liver, stomach and intestinal diseases of Penaeus vannamei test.
试验时间:2015.8.25-.29 Test time: 2015.8.25-.29
试验地点:课题组南美白对虾养殖基地第5塘 Test site: the fifth pond of the research group's vannamei breeding base
方法与结果:第5塘面积1亩,原饲养有10万尾体长5-6cm的南美白对虾虾苗,于2015.8.25上午发现有20%左右对虾苗出现肝脏红肿、肝胰线模糊不清、空肠、拉白便等症状,2015.8.25中午把中药试药组按4-5%拌入对虾饲料中投喂第5塘,每日给药1次,连续给药3日,结果,从给药的第二天开始,空肠、拉白便等症状逐渐消失,给药3天后,肝肠症状明显改变,回转正常。第4、5天继续跟踪观察,对虾的肝、胃、肠功能恢复正常,无空肠、拉白便现象,肝脏颜色恢复健康颜色,对虾饲料由原来的3.0Kg,增加至3.5Kg,1.5小时内吃完。 Methods and results: The fifth pond covers an area of 1 mu. There were 100,000 shrimp juveniles of Penaeus vannamei with a tail length of 5-6cm. On the morning of August 25, 2015, about 20% of the shrimps were found to have red and swollen livers and blurred hepatopancreatic lines. Clearance, jejunum, diarrhea and other symptoms, at noon on August 25, 2015, the Chinese medicine test group was mixed into the prawn feed at 4-5% and fed to the fifth pond, administered once a day for 3 consecutive days, and the result was, From the second day of administration, symptoms such as jejunum and diarrhea gradually disappeared. After 3 days of administration, liver and intestinal symptoms changed significantly and returned to normal. On the 4th and 5th day, the follow-up observation continued, the liver, stomach and intestinal functions of the prawns returned to normal, there was no jejunum and white stool phenomenon, the liver color returned to a healthy color, and the prawn feed was increased from the original 3.0Kg to 3.5Kg, within 1.5 hours finish eating.
结论:本试验提示试药组治疗南美白对虾的肝、胃、肠疾病,有明显治疗效果。 Conclusion: This experiment suggests that the experimental group has obvious curative effect on the liver, stomach and intestinal diseases of Penaeus vannamei.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510720449.XA CN105410346A (en) | 2015-10-30 | 2015-10-30 | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510720449.XA CN105410346A (en) | 2015-10-30 | 2015-10-30 | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105410346A true CN105410346A (en) | 2016-03-23 |
Family
ID=55489267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510720449.XA Pending CN105410346A (en) | 2015-10-30 | 2015-10-30 | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105410346A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106069891A (en) * | 2016-06-13 | 2016-11-09 | 莆田秀屿区群韬农业技术开发有限公司 | A kind of cyclic culture method of prawn |
CN106430471A (en) * | 2016-09-30 | 2017-02-22 | 防城港市金沙海洋科技有限责任公司 | Nano silver sterilizing, detoxifying and immunity enhancing agent used for aquaculture |
CN106973833A (en) * | 2017-03-15 | 2017-07-25 | 广西精工海洋科技有限公司 | To shrimp culture's cultural method |
CN107319193A (en) * | 2017-06-15 | 2017-11-07 | 周海峰 | Penaeus Vannmei fermented brewer's grain feed |
CN108077139A (en) * | 2017-12-26 | 2018-05-29 | 钦州市钦州港高丰水产养殖专业合作社 | Improve the cultural method of Penaeus Vannmei survival rate |
CN111109434A (en) * | 2020-01-20 | 2020-05-08 | 无锡绿水之源生物科技有限公司 | Composite preparation for strengthening intestine and benefiting liver in penaeus vannamei boone culture and preparation method thereof |
CN112790128A (en) * | 2020-12-31 | 2021-05-14 | 亚太海洋生物科技(厦门)有限公司 | Method for preventing Vertically spreading of liver and intestinal sporozoon of Litopenaeus vannamei |
CN114146071A (en) * | 2022-02-08 | 2022-03-08 | 西北农林科技大学深圳研究院 | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415365A (en) * | 2002-10-25 | 2003-05-07 | 广西南宁悦丰天然生物工程有限公司 | Chinese medical preparation for preventing and curing blaze of shrimps corpus hemorrhagicum, gill rot and pond syndrome |
CN1422657A (en) * | 2002-12-06 | 2003-06-11 | 文仁肇 | Chinese medicine capable of making cultured prawn quickly shelling and disinfecting water thereof |
CN103432294A (en) * | 2013-08-29 | 2013-12-11 | 天津生机集团股份有限公司 | Traditional Chinese medicine oral liquid for treating prawn eye disease and preparation method thereof |
CN103877192A (en) * | 2012-12-19 | 2014-06-25 | 青岛中仁药业有限公司 | Compound Chinese herbal medicine capable of promoting growth of prawn, and manufacturing method thereof |
CN104970251A (en) * | 2015-07-07 | 2015-10-14 | 卞佳林 | A feed additive containing traditional Chinese medicine ingredients for banana prawns and a feed preparation method thereof |
-
2015
- 2015-10-30 CN CN201510720449.XA patent/CN105410346A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415365A (en) * | 2002-10-25 | 2003-05-07 | 广西南宁悦丰天然生物工程有限公司 | Chinese medical preparation for preventing and curing blaze of shrimps corpus hemorrhagicum, gill rot and pond syndrome |
CN1422657A (en) * | 2002-12-06 | 2003-06-11 | 文仁肇 | Chinese medicine capable of making cultured prawn quickly shelling and disinfecting water thereof |
CN103877192A (en) * | 2012-12-19 | 2014-06-25 | 青岛中仁药业有限公司 | Compound Chinese herbal medicine capable of promoting growth of prawn, and manufacturing method thereof |
CN103432294A (en) * | 2013-08-29 | 2013-12-11 | 天津生机集团股份有限公司 | Traditional Chinese medicine oral liquid for treating prawn eye disease and preparation method thereof |
CN104970251A (en) * | 2015-07-07 | 2015-10-14 | 卞佳林 | A feed additive containing traditional Chinese medicine ingredients for banana prawns and a feed preparation method thereof |
Non-Patent Citations (1)
Title |
---|
王继芬: "微生态制剂、中药在南美白对虾育苗中的应用", 《科学养鱼》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106069891A (en) * | 2016-06-13 | 2016-11-09 | 莆田秀屿区群韬农业技术开发有限公司 | A kind of cyclic culture method of prawn |
CN106430471A (en) * | 2016-09-30 | 2017-02-22 | 防城港市金沙海洋科技有限责任公司 | Nano silver sterilizing, detoxifying and immunity enhancing agent used for aquaculture |
CN106973833A (en) * | 2017-03-15 | 2017-07-25 | 广西精工海洋科技有限公司 | To shrimp culture's cultural method |
CN107319193A (en) * | 2017-06-15 | 2017-11-07 | 周海峰 | Penaeus Vannmei fermented brewer's grain feed |
CN108077139A (en) * | 2017-12-26 | 2018-05-29 | 钦州市钦州港高丰水产养殖专业合作社 | Improve the cultural method of Penaeus Vannmei survival rate |
CN111109434A (en) * | 2020-01-20 | 2020-05-08 | 无锡绿水之源生物科技有限公司 | Composite preparation for strengthening intestine and benefiting liver in penaeus vannamei boone culture and preparation method thereof |
CN112790128A (en) * | 2020-12-31 | 2021-05-14 | 亚太海洋生物科技(厦门)有限公司 | Method for preventing Vertically spreading of liver and intestinal sporozoon of Litopenaeus vannamei |
CN112790128B (en) * | 2020-12-31 | 2022-06-10 | 亚太海洋生物科技(厦门)有限公司 | Method for preventing Vertically spreading of liver and intestinal sporozoon of Litopenaeus vannamei |
CN114146071A (en) * | 2022-02-08 | 2022-03-08 | 西北农林科技大学深圳研究院 | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome |
CN114146071B (en) * | 2022-02-08 | 2023-02-28 | 西北农林科技大学深圳研究院 | Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102450517B (en) | Broiler feed and traditional Chinese medicine additive used in same | |
CN105410346A (en) | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof | |
CN104256168B (en) | One boar functional feed and preparation method thereof | |
CN104068279B (en) | A kind of eel feed containing Chinese medicine additive and preparation method thereof | |
CN104286486A (en) | Functional feed for treating duck virus hepatitis and preparation method of functional feed for treating duck virus hepatitis | |
CN105166544A (en) | Pig mixed feed and preparation method thereof | |
CN105106894A (en) | Chinese herbal medicine preparation for treating white head-mouth disease of xiphophorus helleri and preparation method thereof | |
CN110755542A (en) | Formula of uric acid-reducing gout-treating tea and preparation method thereof | |
CN105168807B (en) | Traditional Chinese medicine composition for treating porcine blue-ear disease and preparation method thereof | |
CN106173450A (en) | Improve compound feed additive and the feedstuff of pigeon immunity | |
CN105056159A (en) | Medicine for treating parasitic diseases of pigs and preparation method thereof | |
CN103239667B (en) | Chinese traditional medicine for treating foot-and-mouth disease of domestic animals | |
CN106237131A (en) | The Herba Taraxaci oral liquor of lowering blood-fat and reducing weight and oral liquid thereof | |
CN108310136A (en) | A kind of feed addictive and preparation method thereof of prevention white diarrhea | |
CN104056242A (en) | Traditional Chinese medicine composition for treating acute cholecystitis and preparation method thereof | |
CN107625853A (en) | Treat Chinese medicine composition of pig acute festering type gastroenteritis and preparation method thereof | |
CN103099885A (en) | Soft capsules having acne removing function and preparation method thereof | |
CN106177540A (en) | A kind of Herba Taraxaci oral liquid of clearing away heat to alleviate pain and preparation method thereof | |
CN104784491A (en) | Traditional Chinese medicine preparation for treating salpingitis of laying hens and preparation method thereof | |
CN106729589A (en) | Treat the Chinese medicine preparation and preparation method of transmissible gastroenteritis of swine | |
CN107823303A (en) | A kind of strong doctor's external fumigation and washing soup for treating hemorrhoid | |
CN108404007A (en) | A kind of feed addictive and preparation method thereof of prevention necrotic enteritis | |
CN107960535A (en) | A kind of feed addictive and its production method for preventing beef cattle gastroenteritis | |
CN107308254A (en) | Eight positives and preparation method thereof | |
CN105106893A (en) | Chinese herbal medicine feed additive for preventing white head-mouth disease of xiphophorus helleri and preparation method of Chinese herbal medicine feed additive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160323 |